UK risks crisis from rising ill health One in five working age adults in the UK are now unfit to work because of ill health, a government report warned. Rising sickness levels mean that the nation ...

Obesity should not be considered a barrier for a patient who needs a shoulder replacement procedure, researchers argued in a ...

A “sharp growth” in prescription drug spending, including pricey GLP-1 weight-loss medications, helped fuel the increase.

Special Report: Tryptamine Therapeutics has achieved a key milestone in development of its innovative IV-infused psilocin ...

PYC Therapeutics (ASX:PYC) has announced encouraging progress with its investigational drug VP-001, designed to treat Retinitis Pigmentosa type 11 (RP11), a severe genetic eye disorder. The company ...

ReliefNow expands its structured conservative-care model as national organizations continue to report elevated levels of ...

NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients –– Acute unmet need in R/R ...

MSD has announced positive results from its phase 3 CORALreef Lipids trial, showing that enlicitide decanoate, an investigational oral PCSK9 inhibitor, significantly reduced low-density lipoprotein ...

ATLANTA -- An investigational quadruple receptor agonist led to a substantial reduction in total body weight with minimal ...

For the primary endpoint, Eczema Area and Severity Index (EASI) improved by 53-61% in a dose-dependent manner across the ...

Employers expect to see health benefits rise by 6.7% in 2026, reaching more than $18,500 per employee on average, according ...

Another common feature: Patients with a number of autoimmune diseases, especially women, often suffer heart attacks and ...